CME

This program will address the rapidly evolving field of shunt therapy as a treatment for heart failure. Specific populations of heart failure where this therapy may be most applicable will be discussed, along with the specific shunt types currently being tested. Results from studies already reported will be reviewed, combined with a look at the short and longer-term horizons for this therapeutic category.

There is a growing recognition of the prevalence and outcomes associated with tricuspid regurgitation, whether in isolation or with concomitant diseases. This program will focus on defining the burden of disease, outlining current guideline directed medical therapy and discussing the recent evidence for transcatheter therapies. Gaps in our current understanding of this complex disease process will also be examined.